- Home
- SUPN vs AZZ Comparison
SUPN vs AZZ Comparison
Compare SUPN & AZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- AZZ
- Stock Information
- Founded
- SUPN 2005
- AZZ 1956
- Country
- SUPN United States
- AZZ United States
- Employees
- SUPN N/A
- AZZ N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- AZZ Industrial Specialties
- Sector
- SUPN Health Care
- AZZ Industrials
- Exchange
- SUPN Nasdaq
- AZZ Nasdaq
- Market Cap
- SUPN 2.6B
- AZZ 3.0B
- IPO Year
- SUPN 2012
- AZZ N/A
- Fundamental
- Price
- SUPN $46.02
- AZZ $99.97
- Analyst Decision
- SUPN Strong Buy
- AZZ Buy
- Analyst Count
- SUPN 4
- AZZ 7
- Target Price
- SUPN $63.25
- AZZ $115.43
- AVG Volume (30 Days)
- SUPN 1.0M
- AZZ 284.3K
- Earning Date
- SUPN 11-04-2025
- AZZ 10-08-2025
- Dividend Yield
- SUPN N/A
- AZZ 0.80%
- EPS Growth
- SUPN N/A
- AZZ 855.67
- EPS
- SUPN N/A
- AZZ 10.37
- Revenue
- SUPN $681,539,000.00
- AZZ $1,594,766,000.00
- Revenue This Year
- SUPN $8.29
- AZZ $5.28
- Revenue Next Year
- SUPN $22.72
- AZZ $5.12
- P/E Ratio
- SUPN N/A
- AZZ $9.64
- Revenue Growth
- SUPN 4.54
- AZZ 1.55
- 52 Week Low
- SUPN $29.16
- AZZ $70.90
- 52 Week High
- SUPN $57.65
- AZZ $119.95
- Technical
- Relative Strength Index (RSI)
- SUPN 37.29
- AZZ 43.76
- Support Level
- SUPN $43.11
- AZZ $98.14
- Resistance Level
- SUPN $57.34
- AZZ $104.27
- Average True Range (ATR)
- SUPN 2.50
- AZZ 3.00
- MACD
- SUPN -0.98
- AZZ 0.55
- Stochastic Oscillator
- SUPN 19.60
- AZZ 37.64
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About AZZ AZZ Inc.
AZZ Inc is a provider of galvanizing and a variety of metal coating solutions and coil coating solutions to a broad range of end markets in North America. The company's operating segment consists of Metal Coatings, Precoat Metals, and Infrastructure Solutions. The company generates the majority of its revenue from the Precoat Metals segment, which provides coil coating application of protective and decorative coatings and related value-added downstream processing for steel and aluminum coils. Geographically, the company generates the majority of its revenue from the United States.